A recent study differentiated nonalcoholic steatohepatitis (NASH) from alcoholic liver disease showing AST/ALT ratio of 0.9 in NASH and 2.6 in patients with alcoholic liver disease. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.